For 30+ years Dr. Jang has brought novel devices to patients around the world, both as an investor and an entrepreneur. He spent 13 years as general partner with The Vertical Group, and led prominent medtech companies including Kyphon (acquired by Medtronic), Integrated Vascular Systems (acquired by Abbott), Ensure Medical (acquired by J&J), and Embol-X (acquired by Edwards Lifesciences). Before that, Dr. Jang was vice-president of R&D at Boston Scientific and vice-president for R&D at Cardiovascular Imaging Systems. Dr. Jang currently sits on the boards of Tricorntech.
In 2012, Dr. Jang founded Medeon to bring revolutionary solutions to the minimally invasive medtech sector. He has also become a key mentor for young medtech talent; for instance, he co-founded the Stanford-Taiwan Biomedical Fellowship Program (STB), which brings the best young leaders from Taiwan’s medical field to Stanford for multi-disciplinary trainings including biodesign and entrepreneurship.